🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Sponsor trial record
Trackers Companies Trial finder
Sponsor · clinical trials

iVascular clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our France, Spain, Germany, Belgium and Netherlands registers with iVascular as lead sponsor. Synced 26 Sep 2026
8Current trials
3Recruiting now
1Drug in these trials
5Trial registers
Maintained by Sreepriya Prasannan
MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist
Compiled from ClinicalTrials.gov and CTIS registry records · Last verified · Editorial standards
At a glance

iVascular is the lead sponsor of 8 current clinical trials in our France, Spain, Germany, Belgium and Netherlands registers. 3 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are 12-month DAPT. The most-studied condition is Acute Ischemic Stroke.

ClinicalTrials.gov trials by status

  • Recruiting338%
  • Not yet open225%
  • Active, closed225%
  • By invitation113%

Trials by phase

  • Not applicable450%
  • Observational338%
  • Phase 3113%
01

Clinical trials sponsored by iVascular

8 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Clinical Performance and Safety Assessment of the Use of iCover Balloon Expandable Covered Stent (iVascular) Implanted as Bridging Stent in FEVAR (Fenestrated Endovascular Aortic Repair) for the Treatment of Complex Abdominal Aortic Aneurysms
NCT07529275 · ClinicalTrials.gov ↗ · Complex Abdominal Aortic Aneurysms
Not applicable Recruiting 2026-02 Germany, France, Spain, Netherlands, Belgium
Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries
NCT05902923 · ClinicalTrials.gov ↗ · Artery Disease
Observational Recruiting 2023-08 France
Safety and Efficacy Evaluation of the iNstroke 4F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke Due to Primary Distal Medium Vessel Occlusions (DMVO)
NCT07357285 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke
Not applicable Recruiting 2025-11 Germany, Spain
Evaluation of iNstroke Aspiration Catheters for Thrombectomy: a Multi-center Prospective Study
NCT07376447 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke
Not applicable Not yet open 2026-05 Germany, France
Efficacy and Safety Evaluation of iNstroke 5F Aspiration Catheter for Thrombectomy
NCT07571954 · ClinicalTrials.gov ↗ · Acute Ischemic Stroke
Not applicable Not yet open 2026-08 France, Spain
Evaluation of the iCover Stent as a Bridging Stent in Fenestrated Endovascular Aneurysm Repair (fEVAR) for Complex Aortic Aneurysms.
NCT07742254 · ClinicalTrials.gov ↗ · Aortic Aneurysm, Aortic Aneurysm Abdominal
Observational By invitation 2026-03 France
Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy
NCT05952206 · ClinicalTrials.gov ↗ · Coronary Artery Disease
Phase 3 Active, closed 2023-10 France, Spain, Belgium
Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease
NCT05192616 · ClinicalTrials.gov ↗ · Angioplasty, Peripheral Arterial Disease, Iliac Artery Disease
Observational Active, closed 2022-04 Germany, France, Spain, Belgium

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Drugs in iVascular trials

1 compound

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

03

Conditions in iVascular trials

10 conditions
Acute Ischemic Stroke3Complex Abdominal Aortic Aneurysms1Angioplasty1Peripheral Arterial Disease1Iliac Artery Disease1Covered Stent1Artery Disease1Coronary Artery Disease1Aortic Aneurysm1Aortic Aneurysm Abdominal1
04

By trial register

RegisterTrialsRecruiting
Clinical trials in France72
Clinical trials in Spain52
Clinical trials in Germany42
Clinical trials in Belgium31
Clinical trials in Netherlands11

A trial with sites in more than one country appears in each of those registers.

05

Other sponsors in Acute Ischemic Stroke

SponsorTrials
Capital Medical University14
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University7
Xuanwu Hospital, Beijing6
Universitätsklinikum Hamburg-Eppendorf4
Nanfang Hospital, Southern Medical University4
Beijing Anzhen Hospital4
Yi Yang4
The First Affiliated Hospital of University of Science and Technology of China4
The First Affiliated Hospital of Zhengzhou University3
Xiang Luo3

Sponsors with the most current trials registered for this condition.

06

Questions about iVascular trials

How many clinical trials does iVascular sponsor?

iVascular is the lead sponsor of 8 current trials on ClinicalTrials.gov in our France, Spain, Germany, Belgium and Netherlands registers, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are iVascular trials recruiting?

Yes. 3 of its 8 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is iVascular testing?

Its current trials name 1 drug or biological as interventions. The most frequent are 12-month DAPT (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.